0000950170-23-054380.txt : 20231020 0000950170-23-054380.hdr.sgml : 20231020 20231020161638 ACCESSION NUMBER: 0000950170-23-054380 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231018 FILED AS OF DATE: 20231020 DATE AS OF CHANGE: 20231020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adams Laura Lee CENTRAL INDEX KEY: 0001891764 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 231337336 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 ownership.xml 4 X0508 4 2023-10-18 0001492674 T2 Biosystems, Inc. TTOO 0001891764 Adams Laura Lee 101 HARTWELL AVENUE LEXINGTON MA 02421 true false false false false Common Stock 2023-10-18 4 M false 7 A 37 D Restricted Stock Units 2023-10-18 4 M false 7 0.00 D Common Stock 7 7 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On October 18, 2021 the reporting person was granted 21 RSU's that vest in three equal annual installments commencing on October 18, 2022. /s/ John Sprague, Attorney-in-fact 2023-10-20